Company Overview of Xeragon, Inc.
Xeragon Inc. develops and markets products and services focusing on oligoribonucleotides (RNA). The company’s TOM-Amidite technology allows chemical synthesis of RNA and its siRNA technology helps in RNA synthesis and gene silencing. Xeragon’s products and services are used by RNA scientists in the fields of biopharmaceuticals, diagnostics, therapeutics, and structural studies. Xeragon Inc. was founded in 1997 and is headquartered in Huntsville, Alabama. In April 2002, QIAGEN N.V. (Nasdaq: QGENF) completed its acquisition of Xeragon Inc. as a subsidiary.
2307 Spring Branch Road
Huntsville, AL 35801
Founded in 1997
Key Executives for Xeragon, Inc.
Xeragon, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Xeragon, Inc., please visit www.xeragon.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.